TY - JOUR
T1 - Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections
AU - Skoll, Katharina
AU - Palmetzhofer, Julia
AU - Lummerstorfer, Maria
AU - Anzengruber, Maria
AU - Gabor, Franz
AU - Wirth, Michael
N1 - Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of uropathogenic Escherichia coli. In advanced drug delivery systems, a similar, glycan-mediated targeting mechanism may be realized by conjugating the drug to a plant lectin, like wheat germ agglutinin (WGA). We introduce a drug delivery vehicle consisting of human serum albumin as nanoparticle shell, olive oil as core component, the active pharmaceutical ingredients (API) trimethoprim and rifampicin as well as WGA to facilitate cellular internalization. When WGA was embedded into the proteinaceous particle shell, cell binding studies revealed up to 60 % higher cell binding potential. Additionally, nanoparticles showed a good efficacy against gram-negative just as against gram-positive bacteria. The combination of the promising cell-associative properties and the proven antimicrobial potential might lead to an improved efficacy of advanced treatment of UTIs.
AB - Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of uropathogenic Escherichia coli. In advanced drug delivery systems, a similar, glycan-mediated targeting mechanism may be realized by conjugating the drug to a plant lectin, like wheat germ agglutinin (WGA). We introduce a drug delivery vehicle consisting of human serum albumin as nanoparticle shell, olive oil as core component, the active pharmaceutical ingredients (API) trimethoprim and rifampicin as well as WGA to facilitate cellular internalization. When WGA was embedded into the proteinaceous particle shell, cell binding studies revealed up to 60 % higher cell binding potential. Additionally, nanoparticles showed a good efficacy against gram-negative just as against gram-positive bacteria. The combination of the promising cell-associative properties and the proven antimicrobial potential might lead to an improved efficacy of advanced treatment of UTIs.
KW - Humans
KW - Anti-Bacterial Agents/pharmacology
KW - Serum Albumin, Human
KW - Drug Delivery Systems
KW - Pharmaceutical Preparations
KW - Wheat Germ Agglutinins/chemistry
KW - Excipients
KW - Bacterial Infections/drug therapy
KW - Nanoparticles/chemistry
KW - Urinary Tract Infections/drug therapy
KW - Human serum albumin
KW - Drug delivery
KW - Nanoparticles
KW - Antibiotic
KW - Urinary tract infection
KW - Wheat germ agglutinin
UR - http://www.scopus.com/inward/record.url?scp=85154587743&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2023.102685
DO - 10.1016/j.nano.2023.102685
M3 - Article
C2 - 37105340
SN - 1549-9634
VL - 50
JO - Nanomedicine - Nanotechnology Biology and Medicine
JF - Nanomedicine - Nanotechnology Biology and Medicine
M1 - 102685
ER -